EOMES and hepatocellular carcinoma: ​In hepatocellular carcinoma, itaconate promotes CD8+ T cell exhaustion by enhancing H3K4me3 histone modifications at the promoter region of the transcription factor Eomesodermin (EOMES), leading to PD-1 and TIM-3 expression [141].